Literature DB >> 23582238

Weight change at 12 months in users of three progestin-only contraceptive methods.

Zevidah Vickery1, Tessa Madden, Qiuhong Zhao, Gina M Secura, Jenifer E Allsworth, Jeffrey F Peipert.   

Abstract

BACKGROUND: Concerns about weight gain may influence contraceptive use. We compared the change in body weight over the first 12 months of use between women using the etonogestrel (ENG) implant, the levonorgestrel intrauterine system (LNG-IUS) or depot medroxyprogesterone acetate (DMPA) with women using the copper intrauterine device (IUD). STUDY
DESIGN: This was a substudy of the Contraceptive CHOICE Project, a prospective cohort study of 9256 women provided no-cost contraception. Women who had been using the ENG implant, LNG-IUS, DMPA or copper IUD continuously for at least 11 months were eligible for participation. We obtained body weight at enrollment and at 12 months and compared the weight change for each progestin-only method to the copper IUD.
RESULTS: We enrolled a total of 427 women: 130 ENG implant users, 130 LNG-IUS users, 67 DMPA users and 100 copper IUD users. The mean weight change (in kilograms) over 12 months was 2.1 for ENG implant users [standard deviation (SD)=6.7]; 1.0 for LNG-IUS users (SD=5.3); 2.2 for DMPA users (SD=4.9) and 0.2 for copper IUD users (SD=5.1). The range of weight change was broad across all contraceptive methods. In the unadjusted linear regression model, ENG implant and DMPA use were associated with weight gain compared to the copper IUD. However, in the adjusted model, no difference in weight gain with the ENG implant, LNG-IUS or DMPA was observed. Only Black race was associated with significant weight gain (1.3 kg, 95% confidence interval=0.2-2.4) when compared to other racial groups.
CONCLUSIONS: Weight change was variable among women using progestin-only contraceptives. Black race was a significant predictor of weight gain among contraceptive users.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraception; Copper intrauterine device; Etonogestrel implant; Levonorgestrel intrauterine system; Weight change

Mesh:

Substances:

Year:  2013        PMID: 23582238      PMCID: PMC3951762          DOI: 10.1016/j.contraception.2013.03.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  16 in total

1.  Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.

Authors:  Satu Suhonen; Maija Haukkamaa; Tell Jakobsson; Ilkka Rauramo
Journal:  Contraception       Date:  2004-05       Impact factor: 3.375

2.  Body weight and composition in users of levonorgestrel-releasing intrauterine system.

Authors:  Natália Dal'Ava; Luis Bahamondes; M Valeria Bahamondes; Allan de Oliveira Santos; Ilza Monteiro
Journal:  Contraception       Date:  2012-03-23       Impact factor: 3.375

3.  Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.

Authors:  M K Clark; J S Dillon; M Sowers; S Nichols
Journal:  Int J Obes (Lond)       Date:  2005-10       Impact factor: 5.095

4.  The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.

Authors:  Gina M Secura; Jenifer E Allsworth; Tessa Madden; Jennifer L Mullersman; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2010-06-11       Impact factor: 8.661

5.  Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.

Authors:  Fatim Lakha; Anna F Glasier
Journal:  Contraception       Date:  2006-07-17       Impact factor: 3.375

6.  Weight gain trends across sociodemographic groups in the United States.

Authors:  Khoa Dang Truong; Roland Sturm
Journal:  Am J Public Health       Date:  2005-07-28       Impact factor: 9.308

7.  Race/ethnicity, life-course socioeconomic position, and body weight trajectories over 34 years: the Alameda County Study.

Authors:  Peter T Baltrus; John W Lynch; Susan Everson-Rose; Trivellore E Raghunathan; George A Kaplan
Journal:  Am J Public Health       Date:  2005-07-28       Impact factor: 9.308

8.  Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data.

Authors:  Nupur D Kittur; Gina M Secura; Jeffrey F Peipert; Tessa Madden; Lawrence B Finer; Jenifer E Allsworth
Journal:  Contraception       Date:  2010-11-23       Impact factor: 3.375

9.  Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.

Authors:  Abbey B Berenson; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

10.  Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.

Authors:  Márcia Pantoja; Tatiane Medeiros; Maria Carolina Baccarin; Sirlei Siani Morais; Luis Bahamondes; Arlete Maria dos Santos Fernandes
Journal:  Contraception       Date:  2009-12-02       Impact factor: 3.375

View more
  22 in total

Review 1.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

Review 2.  Contraceptive care for Canadian youth.

Authors:  Giuseppina Di Meglio; Colleen Crowther; Joanne Simms
Journal:  Paediatr Child Health       Date:  2018-06-12       Impact factor: 2.253

3.  An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.

Authors:  Aaron Lazorwitz; Eva Dindinger; Margaret Harrison; Christina L Aquilante; Jeanelle Sheeder; Stephanie Teal
Journal:  Contraception       Date:  2020-05-12       Impact factor: 3.375

Review 4.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2013-07-02

Review 5.  Contraception for Adolescents and Young Women with Type 2 Diabetes-Specific Considerations.

Authors:  Paulina M Merino; Ethel Codner
Journal:  Curr Diab Rep       Date:  2022-02-12       Impact factor: 4.810

6.  The contraceptive CHOICE project round up: what we did and what we learned.

Authors:  Colleen McNicholas; Tessa Madden; Gina Secura; Jeffrey F Peipert
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

7.  BODY WEIGHT CHANGES IN WOMEN USING IMPLANON IN JOS, NIGERIA.

Authors:  V C Pam; J Musa; J T Mutihir; J A Karshima; C U Anyaka; A S Sagay
Journal:  Afr J Med Med Sci       Date:  2014-09

8.  Changes in body composition in women using long-acting reversible contraception.

Authors:  Priscilla de Nazaré Silva Dos Santos; Tessa Madden; Karen Omvig; Jeffrey F Peipert
Journal:  Contraception       Date:  2016-12-30       Impact factor: 3.375

Review 9.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08

Review 10.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.